5 Einträge gefunden

1. Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target?

   1. Clauditz, Till Sebastian
   2. Gontarewicz, Artur
   3. Bokemeyer, Carsten
   4. Sauter, Guido
   5. Knecht, Rainald
   6. Münscher, Adrian
   7. Wilczak, Waldemar

   2013 - Forschungsinformationssystem des UKE
2. Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.

   1. Clauditz, Till
   2. Gontarewicz, Artur
   3. Lebok, Patrick
   4. Tsourlakis, Maria Christina
   5. Grob, Tobias
   6. Münscher, Adrian
   7. Sauter, Guido

   2012 - Forschungsinformationssystem des UKE
3. Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

   1. Balabanov, Stefan
   2. Gontarewicz, Artur
   3. von Amsberg, Gunhild
   4. Raddrizzani, Laura
   5. Balabanov, Melanie
   6. Bosotti, Roberta
   7. Moll, Jürgen

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
4. Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.

   1. Gontarewicz, Artur
   2. Balabanov, Stefan
   3. von Amsberg, Gunhild
   4. Colombo, Riccardo
   5. Graziano, Alessio
   6. Pesenti, Enrico
   7. Benten, Daniel

   2008 - Forschungsinformationssystem des UKE
5. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.

   1. Gontarewicz, Artur
   2. Balabanov, Stefan
   3. von Amsberg, Gunhild
   4. Panse, Jens
   5. Schafhausen, Philippe
   6. Bokemeyer, Carsten
   7. Fiedler, Walter

   2008 - Forschungsinformationssystem des UKE